Intensity Therapeutics

1 follower


Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers.

Industries

Headquarters

Stage

Employees

Links

Org chart

Lewis H. Bender
Founder & CEO

Lewis H. Bender

Collapse
Brian Schwartz
EVP, Clinical Development
Steve Innaimo
VP, Project Management
John Wesolowski
Principal Accounting Officer And Controller
Karen Du
Director